Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura

Vincenzo Davide Palumbo, Giuseppe Damiano, Massimo Cajozzo, Giuseppe Buscemi, Salvatore Buscemi, Attilio Ignazio Lo Monte, Salvatore Fazzotta, Caternicchia, Carolina Maione, Cocchiara, Attilio Ignazio Lo Monte, Vincenzo Davide Palumbo, Massimo Cajozzo, Salvatore Buscemi, Carolina Maione, Gabriele Spinelli, Gerlando Cocchiara, Silvia Ficarella

Risultato della ricerca: Article

2 Citazioni (Scopus)

Abstract

INTRODUCTION: Hyperparathyroidism is an alteration of the pathophysiological parathyroid hormone (PTH) secretion due or an independent and abnormal release (primary or tertiary hyperparathyroidism) by the parathyroid or an alteration of calcium homeostasis that stimulates the excessive production of parathyroid hormone (secondary hyperparathyroidism).AIMS: There is not a standard, clinical or surgical, treatment for hyperparathyroidism. We review current diagnostic and therapeutic methods.DISCUSSION: In secondary hyperparathyroidism (2HPT) there is a progressive hyperplasia of the parathyroid glands and an increased production of parathyroid hormone. Several causes are proposed: chronic renal insufficiency, vitamin D deficiency, malabsorption syndrome. The tertiary hyperparathyroidism (3HPT) is considered a state of excessive autonomous secretion of PTH due to long-standing 2HPT and it's usually the result of a lack of suppression in the production of PTH. The pathophysiological implications are both skeletal and extraskeletal: it damages the cardiovascular system, nervous system, immune, hematopoietic and endocrine system. The introduction of new drugs has improved the survival of these patients, allowing the inhibition of the synthesis of PTH. Indication for surgical treatment is unresponsive medical therapy.CONCLUSIONS: There are no large prospective studies that comparing the medical and surgical treatment. The choice is not unique and we have to consider the singolar case and the clinical condition of the patient.
Lingua originaleItalian
pagine (da-a)158-167
Numero di pagine10
RivistaDefault journal
Volume168
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo

Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura. / Palumbo, Vincenzo Davide; Damiano, Giuseppe; Cajozzo, Massimo; Buscemi, Giuseppe; Buscemi, Salvatore; Lo Monte, Attilio Ignazio; Fazzotta, Salvatore; Caternicchia; Maione, Carolina; Cocchiara; Ignazio Lo Monte, Attilio; Palumbo, Vincenzo Davide; Cajozzo, Massimo; Buscemi, Salvatore; Maione, Carolina; Spinelli, Gabriele; Cocchiara, Gerlando; Ficarella, Silvia.

In: Default journal, Vol. 168, 2017, pag. 158-167.

Risultato della ricerca: Article

Palumbo, VD, Damiano, G, Cajozzo, M, Buscemi, G, Buscemi, S, Lo Monte, AI, Fazzotta, S, Caternicchia, Maione, C, Cocchiara, Ignazio Lo Monte, A, Palumbo, VD, Cajozzo, M, Buscemi, S, Maione, C, Spinelli, G, Cocchiara, G & Ficarella, S 2017, 'Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura', Default journal, vol. 168, pagg. 158-167.
Palumbo, Vincenzo Davide ; Damiano, Giuseppe ; Cajozzo, Massimo ; Buscemi, Giuseppe ; Buscemi, Salvatore ; Lo Monte, Attilio Ignazio ; Fazzotta, Salvatore ; Caternicchia ; Maione, Carolina ; Cocchiara ; Ignazio Lo Monte, Attilio ; Palumbo, Vincenzo Davide ; Cajozzo, Massimo ; Buscemi, Salvatore ; Maione, Carolina ; Spinelli, Gabriele ; Cocchiara, Gerlando ; Ficarella, Silvia. / Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura. In: Default journal. 2017 ; Vol. 168. pagg. 158-167.
@article{1c95ce8375ea4546903c4c158fbd8908,
title = "Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura",
abstract = "INTRODUCTION: Hyperparathyroidism is an alteration of the pathophysiological parathyroid hormone (PTH) secretion due or an independent and abnormal release (primary or tertiary hyperparathyroidism) by the parathyroid or an alteration of calcium homeostasis that stimulates the excessive production of parathyroid hormone (secondary hyperparathyroidism).AIMS: There is not a standard, clinical or surgical, treatment for hyperparathyroidism. We review current diagnostic and therapeutic methods.DISCUSSION: In secondary hyperparathyroidism (2HPT) there is a progressive hyperplasia of the parathyroid glands and an increased production of parathyroid hormone. Several causes are proposed: chronic renal insufficiency, vitamin D deficiency, malabsorption syndrome. The tertiary hyperparathyroidism (3HPT) is considered a state of excessive autonomous secretion of PTH due to long-standing 2HPT and it's usually the result of a lack of suppression in the production of PTH. The pathophysiological implications are both skeletal and extraskeletal: it damages the cardiovascular system, nervous system, immune, hematopoietic and endocrine system. The introduction of new drugs has improved the survival of these patients, allowing the inhibition of the synthesis of PTH. Indication for surgical treatment is unresponsive medical therapy.CONCLUSIONS: There are no large prospective studies that comparing the medical and surgical treatment. The choice is not unique and we have to consider the singolar case and the clinical condition of the patient.",
author = "Palumbo, {Vincenzo Davide} and Giuseppe Damiano and Massimo Cajozzo and Giuseppe Buscemi and Salvatore Buscemi and {Lo Monte}, {Attilio Ignazio} and Salvatore Fazzotta and Caternicchia and Carolina Maione and Cocchiara and {Ignazio Lo Monte}, Attilio and Palumbo, {Vincenzo Davide} and Massimo Cajozzo and Salvatore Buscemi and Carolina Maione and Gabriele Spinelli and Gerlando Cocchiara and Silvia Ficarella",
year = "2017",
language = "Italian",
volume = "168",
pages = "158--167",
journal = "Default journal",

}

TY - JOUR

T1 - Il trattamento medico e chirurgico nei pazienti affetti da iperparatiroidismo secondario e terziario. Revisione della letteratura

AU - Palumbo, Vincenzo Davide

AU - Damiano, Giuseppe

AU - Cajozzo, Massimo

AU - Buscemi, Giuseppe

AU - Buscemi, Salvatore

AU - Lo Monte, Attilio Ignazio

AU - Fazzotta, Salvatore

AU - Caternicchia, null

AU - Maione, Carolina

AU - Cocchiara, null

AU - Ignazio Lo Monte, Attilio

AU - Palumbo, Vincenzo Davide

AU - Cajozzo, Massimo

AU - Buscemi, Salvatore

AU - Maione, Carolina

AU - Spinelli, Gabriele

AU - Cocchiara, Gerlando

AU - Ficarella, Silvia

PY - 2017

Y1 - 2017

N2 - INTRODUCTION: Hyperparathyroidism is an alteration of the pathophysiological parathyroid hormone (PTH) secretion due or an independent and abnormal release (primary or tertiary hyperparathyroidism) by the parathyroid or an alteration of calcium homeostasis that stimulates the excessive production of parathyroid hormone (secondary hyperparathyroidism).AIMS: There is not a standard, clinical or surgical, treatment for hyperparathyroidism. We review current diagnostic and therapeutic methods.DISCUSSION: In secondary hyperparathyroidism (2HPT) there is a progressive hyperplasia of the parathyroid glands and an increased production of parathyroid hormone. Several causes are proposed: chronic renal insufficiency, vitamin D deficiency, malabsorption syndrome. The tertiary hyperparathyroidism (3HPT) is considered a state of excessive autonomous secretion of PTH due to long-standing 2HPT and it's usually the result of a lack of suppression in the production of PTH. The pathophysiological implications are both skeletal and extraskeletal: it damages the cardiovascular system, nervous system, immune, hematopoietic and endocrine system. The introduction of new drugs has improved the survival of these patients, allowing the inhibition of the synthesis of PTH. Indication for surgical treatment is unresponsive medical therapy.CONCLUSIONS: There are no large prospective studies that comparing the medical and surgical treatment. The choice is not unique and we have to consider the singolar case and the clinical condition of the patient.

AB - INTRODUCTION: Hyperparathyroidism is an alteration of the pathophysiological parathyroid hormone (PTH) secretion due or an independent and abnormal release (primary or tertiary hyperparathyroidism) by the parathyroid or an alteration of calcium homeostasis that stimulates the excessive production of parathyroid hormone (secondary hyperparathyroidism).AIMS: There is not a standard, clinical or surgical, treatment for hyperparathyroidism. We review current diagnostic and therapeutic methods.DISCUSSION: In secondary hyperparathyroidism (2HPT) there is a progressive hyperplasia of the parathyroid glands and an increased production of parathyroid hormone. Several causes are proposed: chronic renal insufficiency, vitamin D deficiency, malabsorption syndrome. The tertiary hyperparathyroidism (3HPT) is considered a state of excessive autonomous secretion of PTH due to long-standing 2HPT and it's usually the result of a lack of suppression in the production of PTH. The pathophysiological implications are both skeletal and extraskeletal: it damages the cardiovascular system, nervous system, immune, hematopoietic and endocrine system. The introduction of new drugs has improved the survival of these patients, allowing the inhibition of the synthesis of PTH. Indication for surgical treatment is unresponsive medical therapy.CONCLUSIONS: There are no large prospective studies that comparing the medical and surgical treatment. The choice is not unique and we have to consider the singolar case and the clinical condition of the patient.

UR - http://hdl.handle.net/10447/226615

M3 - Article

VL - 168

SP - 158

EP - 167

JO - Default journal

JF - Default journal

ER -